Stonepine Capital Management as of June 30, 2022
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 25 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 20.5 | $44M | 6.3M | 6.99 | |
| Cti Biopharma | 10.2 | $22M | 3.7M | 5.97 | |
| Xeris Pharmaceuticals (XERS) | 8.3 | $18M | 12M | 1.54 | |
| Adma Biologics (ADMA) | 6.4 | $14M | 7.0M | 1.98 | |
| Amarin Corp Plc - Spons Adr New (AMRN) | 6.1 | $13M | 8.9M | 1.49 | |
| Quidel Corp (QDEL) | 5.4 | $12M | 120k | 97.18 | |
| Rezolute Com New (RZLT) | 4.5 | $9.7M | 3.0M | 3.23 | |
| Optinose (OPTN) | 4.5 | $9.6M | 2.6M | 3.66 | |
| Urogen Pharma (URGN) | 4.2 | $9.1M | 1.1M | 8.19 | |
| Ligand Pharmaceuticals Com New (LGND) | 4.2 | $8.9M | 100k | 89.22 | |
| Affimed Therapeutics B V | 4.1 | $8.7M | 3.1M | 2.77 | |
| Apollo Endosurgery | 3.7 | $7.9M | 2.2M | 3.65 | |
| Ovid Therapeutics (OVID) | 3.5 | $7.5M | 3.5M | 2.15 | |
| Exagen (XGN) | 3.4 | $7.2M | 1.3M | 5.74 | |
| Castle Biosciences (CSTL) | 3.0 | $6.5M | 295k | 21.95 | |
| Conformis | 2.8 | $6.1M | 17M | 0.35 | |
| Diamedica Therapeutics Com New (DMAC) | 1.1 | $2.4M | 1.2M | 2.02 | |
| Aerie Pharmaceuticals | 0.9 | $1.9M | 251k | 7.50 | |
| Opiant Pharmaceuticals | 0.8 | $1.8M | 152k | 11.99 | |
| Atyr Pharma Com New (LIFE) | 0.8 | $1.7M | 602k | 2.83 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.5 | $1.2M | 242k | 4.84 | |
| Xoma Corp Com New (XOMA) | 0.5 | $1.0M | 46k | 22.28 | |
| Biosante Pharmaceuticals (ANIP) | 0.4 | $854k | 29k | 29.65 | |
| Synlogic | 0.0 | $107k | 93k | 1.15 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $102k | 208k | 0.49 |
